Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

Clinical trial NCT05162768 · COMPLETED

Trial details

NCT number: NCT05162768
Sponsor: Stealth BioTherapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mitochondrial Myopathies Mitochondrial Pathology Mitochondrial DNA Mutation Mitochondrial Diseases Mitochondrial DNA Deletion Mitochondrial DNA Depletion Mitochondrial Metabolism Defect Mitochondrial Complex I Deficiency

Start date: 2022-04-29
Primary completion: 2024-09-30
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.